A Study of QLS5133 Monotherapy in Advanced Solid Tumors

NCT07061639 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
212
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Qilu Pharmaceutical Co., Ltd.